Online edition of India's National Newspaper
Thursday, Jul 01, 2004

About Us
Contact Us
Business
News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts:
Classifieds | Employment |

Business - Briefly Printer Friendly Page   Send this Article to a Friend

Dr. Reddy's R & D effort pays

HYDERABAD: The emphasis laid on R&D by Dr. Reddy's Laboratories is paying off and it now has eight promising molecules in pre-clinical or clinical stage, covering metabolic disorders, cancer, cardiovascular and bacterial infections, according to K. Anji Reddy, Chairman.

In a message to the shareholders (AGM to be held on July 28), Mr. Reddy said the year 2003-04 saw the company commencing its first clinical trial programme in Canada on DRF 10945 for treatment of dyslipidemia. "We now have four molecules in clinical development-3 being pursued by the company and the fourth licensed to Novo Nordisk".

Our special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts:
Classifieds | Employment | Updates: Breaking News |

BL Mumbai Launch


News Update


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu